Global Dna Sequencing Product Share, Growth Trends And Forecast Report 2017-2022

1

 Global DNA Sequencing Products Market to Reach
US 9 Billion
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
 Global DNA Sequencing Products Market to Reach
US 9 Billion The global DNA sequencing
products market has been witnessing a positive
growth. This can be attributed to the confluence
of declining prices of sequencing and increasing
development in sequencing technologies. The
latest report by IMARC Group, titled DNA
Sequencing Products Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2017-2022, finds that the global DNA
sequencing products market reached a value of
more than US 3 Billion in 2016. Over the past
few decades, DNA sequencing has become an
important part of biology and other sciences. It
ascertains the physical order of four bases of
DNA which include adenine, guanine, thymine, and
cytosine. Apart from this, DNA sequencing is also
used for measuring the sequence of individual
genes, entire genomes and full chromosomes of any
organism. Some advantages offered by DNA
sequencing include high accuracy and speed, low
cost and precise results from low sample
input. Request Sample of the Report
http//www.imarcgroup.com/request?typereportid8
39flagB
4
Report Description and Highlights
5
Report Description and Highlights
Report Description

• Highlights of the global DNA sequencing products
  market
• Advancements in technology act as a major factor
  bolstering the growth of the market.
• Research organisations represent the largest
  application area accounting for the majority of
  the global share.
• North America is the leading market for DNA
  sequencing products.
• In recent years, a number of manufacturers
  across the globe have invested in several RD
  projects due to which there have been
  technological developments in personalised
  medicines. For instance, an international
  scientific research project, namely, the Human
  Genome Project brought about a major
  transformation in DNA sequencing technologies.
  Medical facilities are now offering
  sequencing-based treatments, quantitative
  assessments of genomic sequences and rapid DNA
  sequencer for large-scale and Sanger sequencing.
  This, in turn, has positively contributed to the
  growth of the global DNA sequencing products
  market. As a result, global DNA sequencing
  products market is further expected to reach a
  value of more than US 9 Billion, exhibiting a
  CAGR of more than 19 during 2017-2022.
• .
• Read full report _at_ http//www.imarcgroup.com/dna-s
  equencing-products-market

6
Report Description and Highlights
Report Description

• On the basis of product type, consumables and
  reagents currently exhibit a clear dominance in
  the market, followed by equipment. Based on
  application, research organisations represent the
  largest application area of DNA sequencing
  products market. It is followed by hospitals,
  pharmaceutical and life science companies.
  Region-wise, North America accounts for the
  majority of the total global share. This is due
  to declining costs of sequencing along with the
  presence of well-established vendors in the
  region. Other major markets include Europe,
  Asia-Pacific, Latin America and Middle East and
  Africa. The competitive landscape of the market
  has also been analysed with some of the key
  players operating in the market being Illumina
  Inc., Thermo Fisher Scientific Inc., Roche
  Diagnostics, Pacific Biosciences of California,
  Inc. and Beckman Coulter.
• The report by IMARC Group has examined the
  global DNA sequencing products market on the
  basis
• Product Type
• Consumables and Reagents
• Equipment
• Application
• Research Organisations
• Hospitals, Pharmaceutical and Life Science
  Companies
•  

7
Report Description and Highlights
Report Description

• Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• Key Players
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• Pacific Biosciences of California, Inc.
• Beckman Coulter
• Browse More Related Report http//www.imarcgrou
  p.com/categories/healthcare-market-research-report
  s

8
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
9

Contact Us